Yüklüyor......
Role of Immunotherapy for Renal Cell Cancer in 2011
High-dose interleukin-2 (HD IL-2) and interferon were the most commonly administered therapies before the recent introduction of targeted agents, including vascular endothelial growth factor and mammalian target of rapamycin pathway inhibitors. Although the new agents result in a progression-free su...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4020430/ https://ncbi.nlm.nih.gov/pubmed/21917625 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|